Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Other Non-Current Assets of $12.0 million for Q4 2025, little changed year-on-year from $12.0 million in Q4 2024, and little changed on a QoQ basis from $12.0 million in Q4 2024.

Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Other Non-Current Assets for 7 consecutive years, with $12.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $12.0 million, changed 0.0% from the prior year.
  • Other Non-Current Assets steadied at $12.0 million in Q4 2025 per CURLF's latest filing, from $12.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CURLF reached as high as $17.7 billion in Q1 2022 and fell as low as $8.2 million in Q3 2024.
  • A 5-year average of $1.2 billion and a median of $17.6 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Other Non-Current Assets tumbled 81.66% — and 2022, when it surged 57395.28%.
  • Year by year, Other Non-Current Assets stood at $24.3 million in 2021, then slumped by 36.27% to $15.5 million in 2022, then tumbled by 44.37% to $8.6 million in 2023, then jumped by 39.53% to $12.0 million in 2024, then changed by 0.0% to $12.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $12.0 million, $12.0 million, and $8.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 12.00 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 8.16 Mn
Jun 30, 2024 9.11 Mn
Dec 31, 2023 8.60 Mn
Sep 30, 2023 11.18 Mn
Jun 30, 2023 46.79 Mn
Dec 31, 2022 15.46 Mn
Sep 30, 2022 18.95 Mn
Jun 30, 2022 17.61 Mn
Mar 31, 2022 17.67 Bn
Dec 31, 2021 24.26 Mn
Sep 30, 2021 22.88 Mn
Jun 30, 2021 45.21 Mn
Mar 31, 2021 30.73 Mn
Dec 31, 2020 132.23 Mn
Sep 30, 2020 34.34 Mn
Dec 31, 2019 8.83 Mn
Sep 30, 2019 -20.09 Mn